Carla Buccione

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Advanced melanoma patients have an extremely poor long term prognosis and are in strong need of new therapies. The recently developed targeted therapies have resulted in a marked antitumor effect, but most responses are partial and some degree of toxicity remain the major concerns. Dendritic cells play a key role in the activation of the immune system and(More)
  • 1